A Phase II study of Paclitaxel and Vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer:  double tubulin targeting

journal contribution

posted on 2024-06-13, 09:50 authored by S Sewak, S Kosmider, V Ganju, A Woollett, EG Yeow, B Le, MA Debrincat, R Bell, MJ Henry

A Phase II study of Paclitaxel and Vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting

History

Internal medicine journal

40

201-201

Chichester, Eng.

1445-5994

eng

CN.1 Other journal article

2010, The Authors

3

Wiley-Blackwell